Remote Patient Monitoring and Telehealth Markets, 13th Edition

Remote Patient Monitoring and Telehealth Markets, 13th Edition

Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote Patient Monitoring and Telehealth Markets, 13th Edition. This latest edition extends its coverage to include the consumer-grade segment and on-demand telehealth services.

Globally, the patient monitoring and telehealth market continue to expand in both institutional and home segments of the health market, with the United States and many European countries leading the way. This report focuses on global patient monitoring and telehealth market numbers, with specific market coverage for countries such as the United States, Japan, China, Germany, the United Kingdom, Canada, France, Italy, Brazil, and Mexico. Additionally, regional coverage includes North America, Europe, Middle East, Africa (EMEA), Asia Pacific, and Latin America. Sales figures are presented at the manufacturers’ level in U.S. dollars, offering a close comparison to retail levels in many instances.

This 13th edition builds on its predecessor by providing comprehensive coverage in the consumer-grade segment and on-demand telehealth services. The consumer segment has emerged as a significant aspect of the industry in recent years, prompting professional-grade device manufacturers to adapt their product designs and marketing strategies to tap into this new growth opportunity. This shift has impacted various segments, including glucose monitors, heart rate monitors, fetal and pregnancy monitors, pulse oximeters, sleep apnea devices, weight monitoring devices, and other similar product offerings.

While previous editions extensively explored the impact of COVID-19 in 2020 and 2021, the current edition integrates COVID-19 sales into the total revenues for remote patient monitoring and telehealth market segments. This adjustment reflects changes in the way companies report COVID-19 revenues in 2022 and 2023.

The market specifically includes equipment and devices with wireless and remote technologies, patient data processing applications, and features. Basic and manual patient monitoring devices are excluded, as are obsolete glucose monitors incapable of forwarding data to a telehealth record and standard hospital patient monitoring equipment that does not transmit data to a central station.

Key components of the report include:

• Advanced Monitors and Devices: These involve wireless and remote technologies that monitor and transmit data either within an institution via wireless or intranet or at a remote location using wireless transmissions. The covered devices can provide monitoring information beyond a patient room and can offer data for an Electronic Medical Record (EMR) system or are expected to add such features in the forecast period.
• Patient Data Processing Applications and Equipment: This category includes equipment and devices that use algorithms to evaluate monitoring measurements for a patient’s specific condition(s). Typically, physicians can customize these, with reports sent to them. In the market for advanced/remote patient monitoring systems, the applications and equipment are either integrated into the patient monitoring system or added on to the measuring systems.

The base year for the report is 2023, with forecasts provided for each year through 2028. The evaluation of the market considers disease prevalence trends, population trends, device innovations, federal and industry standards and regulations, global penetration, economic influences, and other macro and micro indicators. Both primary and secondary sources were consulted in developing market estimates.